A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
The current study will explore the efficacy, safety and tolerability of 2 dose combinations
of JM-010 to determine the optimal doses of each component to be studied in confirmatory
clinical trials.